UNASSIGNED: Using 2016-2019 National Inpatient Sample data, we identified ≥65-year-old patients admitted for IBD (Crohn\'s, ulcerative colitis) management stratified by delirium presence as a secondary diagnosis. The study aimed to assess delirium\'s impact on geriatric IBD patient outcomes.
UNASSIGNED: Among 67,534 elderly IBD admissions, 0.7% (470) developed delirium. The delirium group had a 4.8-fold increase in in-hospital mortality risk (odds ratio 4.80, P < 0.001, 95% confidence interval [CI] 1.94-11.8). IBD patients with delirium experienced prolonged length of stay (adjusted mean difference 5.15 days, 95% CI 3.24-7.06, P < 0.001) and increased care costs (adjusted mean difference $48,328, 95% CI $26,485-$70,171, P < 0.001) compared to those without delirium.
UNASSIGNED: Elderly IBD patients with delirium face higher mortality risk, prolonged hospitalization, and increased healthcare costs. Clinicians should recognize delirium\'s detrimental effects in this vulnerable group and adhere to preventive protocols for improved care.
■使用2016-2019年全国住院患者样本数据,我们确定了≥65岁的IBD患者(克罗恩病,溃疡性结肠炎)根据谵妄的存在作为次要诊断进行分层处理。本研究旨在评估谵妄对老年IBD患者预后的影响。
■在67,534名老年IBD患者中,0.7%(470)发生谵妄。谵妄组住院死亡风险增加4.8倍(比值比4.80,P<0.001,95%置信区间[CI]1.94-11.8)。出现谵妄的IBD患者住院时间延长(调整后的平均差为5.15天,95%CI3.24-7.06,P<0.001)和增加的护理费用(调整后的平均差异$48,328,95%CI$26,485-$70,171,P<0.001)。
■合并谵妄的老年IBD患者面临更高的死亡风险,住院时间延长,增加医疗费用。临床医生应认识到谵妄对这一弱势群体的有害影响,并遵守预防方案以改善护理。